These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2681438

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
    Kovacs JA, Masur H.
    Clin Infect Dis; 1992 May; 14(5):1005-9. PubMed ID: 1350925
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Preventive pentamidine inhalation of Pneumocystis carinii pneumonia in patients with immune deficiency. Preliminary evaluation of a multicenter study].
    Schrappe-Bächer M, Fätkenheuer G, Salzberger B, Zehrer I, Bendick C, Rasokat H.
    Med Klin (Munich); 1990 Apr; 85 Suppl 2():276-80. PubMed ID: 2197537
    [Abstract] [Full Text] [Related]

  • 5. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
    Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, Kaslow RA.
    N Engl J Med; 1993 Dec 23; 329(26):1922-6. PubMed ID: 7902536
    [Abstract] [Full Text] [Related]

  • 6. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE, Keruly J, Richman DD, Moore RD.
    Arch Intern Med; 1992 Oct 23; 152(10):2009-13. PubMed ID: 1417373
    [Abstract] [Full Text] [Related]

  • 7. The effects of long term zidovudine therapy and Pneumocystis carinii prophylaxis on HIV disease. A review of the literature.
    Hoover DR.
    Drugs; 1995 Jan 23; 49(1):20-36. PubMed ID: 7705214
    [Abstract] [Full Text] [Related]

  • 8. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM, Landman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, Gaudebout C, Certain A, Boué F, Bouvet E.
    N Engl J Med; 1993 May 27; 328(21):1514-20. PubMed ID: 8479488
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prophylaxis against Pneumocystis carinii pneumonia in children infected with HIV.
    Principi N, Marchisio P, Plebani A, Giaquinto C, Picco P.
    Lancet; 1991 May 11; 337(8750):1163. PubMed ID: 1674037
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Ambulatory therapy and prevention of the most frequent HIV-associated opportunistic infections].
    Malinverni R, Blatter M.
    Schweiz Med Wochenschr; 1991 Aug 24; 121(34):1194-204. PubMed ID: 1925448
    [Abstract] [Full Text] [Related]

  • 17. Primary dapsone chemoprophylaxis for Pneumocystis carinii pneumonia in immunocompromised patients infected with the human immunodeficiency virus.
    Lucas CR, Sandland AM, Mijch A, Simpson JM.
    Med J Aust; 1989 Jul 03; 151(1):30-3. PubMed ID: 2528052
    [Abstract] [Full Text] [Related]

  • 18. [Pneumocystis carinii pneumonia and AIDS].
    Szabados A, Boroń-Kaczmarska A, Boroń P.
    Pol Tyg Lek; 1989 Apr 24; 44(17):379-81. PubMed ID: 2626357
    [Abstract] [Full Text] [Related]

  • 19. Prophylaxis of AIDS-related opportunistic infections (OIs).
    Hardy WD.
    AIDS Clin Rev; 1989 Apr 24; ():125-50. PubMed ID: 2562216
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.